Drug profile · INN
pregabalin
LYRICA
- US status
- approved
- Patents linked
- 2
- News articles
- 0
Quick answer
pregabalin (LYRICA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN pregabalin
Brand LYRICA
Route ORAL
Formulation CAPSULE
ATC code N02BF02
Originator Amneal Pharma Europe Ltd
Related patents
Search patents →Frequently asked questions
What is pregabalin?
pregabalin (LYRICA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pregabalin?
LYRICA is a marketed brand name for pregabalin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pregabalin?
pregabalin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.